Asset Details
Do you wish to reserve the book?
Palmitoylation enables MAPK-dependent proteostasis of axon survival factors
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Palmitoylation enables MAPK-dependent proteostasis of axon survival factors
Do you wish to request the book?
Palmitoylation enables MAPK-dependent proteostasis of axon survival factors
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Palmitoylation enables MAPK-dependent proteostasis of axon survival factors
2018
Overview
Axon degeneration is a prominent event in many neurodegenerative disorders. Axon injury stimulates an intrinsic self-destruction program that culminates in activation of the prodegeneration factor SARM1 and local dismantling of damaged axon segments. In healthy axons, SARM1 activity is restrained by constant delivery of the axon survival factor NMNAT2. Elevating NMNAT2 is neuroprotective, while loss of NMNAT2 evokes SARM1-dependent axon degeneration. As a gatekeeper of axon survival, NMNAT2 abundance is an important regulatory node in neuronal health, highlighting the need to understand the mechanisms behind NMNAT2 protein homeostasis. We demonstrate that pharmacological inhibition of the MAP3Ks dual leucine zipper kinase (DLK) and leucine zipper kinase (LZK) elevates NMNAT2 abundance and strongly protects axons from injury-induced degeneration. We discover that MAPK signaling selectively promotes degradation of palmitoylated NMNAT2, as well as palmitoylated SCG10. Conversely, nonpalmitoylated NMNAT2 is degraded by the Phr1/Skp1a/Fbxo45 ligase complex. Combined inactivation of both pathways leads to synergistic accumulation of NMNAT2 in axons and dramatically enhanced protection against pathological axon degeneration. Hence, the subcellular localization of distinct pools of NMNAT2 enables differential regulation of NMNAT2 abundance to control axon survival.
Publisher
National Academy of Sciences
Subject
/ Armadillo Domain Proteins - metabolism
/ Axons
/ Cell Survival - drug effects
/ Cytoskeletal Proteins - metabolism
/ Humans
/ Kinases
/ Leucine
/ MAP Kinase Kinase Kinases - antagonists & inhibitors
/ MAP Kinase Kinase Kinases - metabolism
/ MAP Kinase Signaling System - drug effects
/ MAP Kinase Signaling System - physiology
/ Mice
/ Nerve Degeneration - prevention & control
/ Neurons
/ Nicotinamide-Nucleotide Adenylyltransferase - metabolism
/ Proteins
/ Survival
We currently cannot retrieve any items related to this title. Kindly check back at a later time.